Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Remote Patient Monitoring: What Have We Learned and Where Are We Going?

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Vandenberk et al. reviewed the topic of remote monitoring (RM) of cardiac implantable electronic devices (CIEDs). The publication discusses the clinical benefits of RM, which include improved survival, early detection of actionable events, and more efficient healthcare utilization. The authors emphasized the need for appropriate reimbursement for RM device clinics and the implementation of universal alert programming and data processing to optimize patient care and device clinic workflows. The study concluded that RM should be considered the standard of care for managing patients with CIEDs and implementing adapted healthcare policies to ensure its future manageability.

Access the full-text article here.